Vinita Kailasanath is a partner in the Freshfields Silicon Valley office. She has extensive experience in strategic intellectual property and data-driven transactions in life sciences and technology, and particularly at their intersection. Vinita leads the Freshfields MedTech practice and represents life sciences companies, technology companies, healthcare companies and providers, and investors in connection with the execution of their cutting-edge MedTech and digital health strategies in addition to many of their other complex licenses and collaborations, strategic investments, and R&D and supply agreements. Vinita has advised clients on transactions involving medical devices (including SaMD), wearables, mobile apps, telemedicine, artificial intelligence/machine learning (AI/ML), IoT, software, hardware, pharmaceutical products and biologics, and routinely advises on the intellectual property aspects of mergers, acquisitions, joint ventures and investments.

Prior to becoming a lawyer, Vinita conducted graduate-level neuroendocrinology research; worked in the legal department of a leading alternative energy company specializing in the production of algal oils and bioproducts; and assisted companies with product launches and other marketing and sales matters.

Vinita earned her J.D. from Stanford Law and was Editor-in-Chief of the Stanford Technology Law Review.  After graduation, she clerked for the Hon. Arthur Gajarsa of the U.S. Court of Appeals for the Federal Circuit.  She also earned an MS, Biological Sciences, and BA, Human Biology, from Stanford University and currently serves on the Stanford Law School Board of Visitors.